Leone D Patterson's most recent trade in Zymeworks BC Inc was a trade of 459 Common Stock done at an average price of $10.5 . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zymeworks BC Inc | Leone D Patterson | EVP, Chief Bus & Fin Officer | Grant, award, or other acquisition of securities at price $ 10.55 per share. | 06 Jan 2026 | 459 | 459 (0%) | 0% | 10.5 | 4,842 | Common Stock |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 46,000 | 46,000 | - | - | Stock Option (right to buy) | |
| Kalaris Therapeutics Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Leone D Patterson | EVP, Chief Bus & Fin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | D Patterson Leone | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 95,755 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Leone Patterson D | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 5,201 | 60,755 | - | 5.9 | 30,478 | Common Stock |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 4,452 | 64,542 | - | 3.8 | 16,962 | Common Stock |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 190,000 | 190,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 35,000 | 67,000 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 30,000 | 32,000 | - | 0 | Common Stock | |
| Nkarta Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| Tenaya Therapeutics Inc | Leone D. Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 66,000 | 66,000 | - | - | Stock Option (Right to buy) | |
| Nkarta Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2021 | 16,511 | 16,511 | - | - | Stock Option (right to buy) |